Latest Optimal Industrial Technologies Press Releases

Optimal announces new CEO as Martin Gadsby steps into Chairman role

28th November 2023

The Optimal Group, consisting of Optimal Industrial Automation and Optimal Industrial Technologies, has promoted Eamonn Garry to be Chief Executive Officer and Martin Gadsby to Chairman. In these new roles, the former Operations Director and Vice President will steer the group’s next phase of growth, focused on offering customers future-oriented digital transformation solutions. 

Read more

Optimal sees growth of synTQ user community at latest event

31st October 2023

Optimal Industrial Technologies reported a very successful 2023 synTQ User Group Meeting, experiencing considerable engagement with established and new customers from (bio)pharmaceutical companies around the world. The event, which took place on 18th-20th September at Normandy Farm, near Philadelphia, US, highlighted the latest advances in Process Analytical Technology (PAT) and how synTQ can drive the digitalisation of industry. 

Read more

Optimal shows how to elevate flow chemistry applications at CFC summit

29th September 2023

Optimal Industrial Technologies has announced its sponsorship and participation in the fourth Commercializing Flow Chemistry (CFC) summit, taking place from 16th-18th October in Boston, MA, U.S. Attendees will have an exclusive opportunity to explore Optimal’s digital transformation enabling platform, synTQ. 

Read more

Optimal further strengthens operations with new global sales manager

22nd August 2023

Process Analytical Technology (PAT) leader, Optimal Industrial Technologies, is increasing its support for the growing global demand for data-driven, automated process control strategies with the appointment of Chris Vickers. As global sales manager, he will be responsible for creating new business opportunities while continuing to serve existing customers, enhancing the company’s ability to deliver unparalleled value. 

Read more

Digitalisation in biopharma starts with PAT

With Industry 4.0 quickly becoming an established reality, (bio)pharmaceutical R&D, manufacturing and quality control facilities are implementing novel sensors and analysers that generate complex data. During each digital journey, it is equally significant for companies to set up a suitable framework to derive meaningful insights from data. 

Read more

Next Page »